Ordering Recommendation

Intended for use in patients with viral loads ≥500 copies/mL. HIV-1 phenotyping test to provide antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (ie, NRTI and NNRTI).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (K2 EDTA) or Plasma Preparation Tube (PPT).

Specimen Preparation

Separate from cells within 6 hours of collection. Transfer 3 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 3 mL)

Storage/Transport Temperature

CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Thawed specimens.

Remarks
Stability

Ambient: 6 hours; Refrigerated: 24 hours; Frozen: 2 weeks

Methodology

Polymerase Chain Reaction/Culture

Performed

Varies

Reported

16-26 days

Reference Interval

By report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note

Hotline History

N/A

CPT Codes

87903; 87904 x12

Components

Component Test Code* Component Chart Name LOINC
3000883 EER HIV-1 PhenoSense 11502-2
3000884 HIV-1 PhenoSense 45182-3
3000885 HIV-1 PhenoSense Interpretation 83327-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • HIV resistance testing
  • Human Immunodeficiency Virus (HIV) Phenotype Comprehensive
Human Immunodeficiency Virus Type 1 (HIV-1) PhenoSense

Monogram Biosciences